Literature DB >> 6765415

Species differences in susceptibilities of Proteeae spp. to six cephalosporins and three aminoglycosides.

J L Penner, M A Preston, J N Hennessy, L J Barton, M M Goodbody.   

Abstract

Six cephalosporins and three aminoglycosides were examined for activity against 1,693 isolates belonging to six species of Proteeae. The most notable species-specific differences included the marked susceptibility of Providencia alcalifaciens and Proteus mirabilis to cephalothin, the resistance of Proteus vulgaris to cefamandole, and the resistance of Providencia stuartii to gentamicin and tobramycin. The third-generation cephalosporins cefotaxime and moxalactam were substantially more inhibitory than were cefoperazone, cefamandole, and cefoxitin. P. stuartii, generally the most resistant species, was, however, markedly susceptible to moxalactam and cefotaxime.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6765415      PMCID: PMC183714          DOI: 10.1128/AAC.22.2.218

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Proteus infections in hospital.

Authors:  P STORY
Journal:  J Pathol Bacteriol       Date:  1954-07

2.  In vitro susceptibility of recently isolated strains of Proteus to ten antibiotics.

Authors:  K G POTEE; S S WRIGHT; M FINLAND
Journal:  J Lab Clin Med       Date:  1954-09

3.  Antimicrobial resistance of the genera Proteus, Providencia and Serratia with special reference to multiple resistance patterns.

Authors:  A von Graevenitz; M Nourbakhsh
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

4.  Nosocomially acquired bacteriuria due to Proteus rettgeri and Providencia stuartii.

Authors:  J A Washington; D H Senjem; A Haldorson; A H Schutt; W J Martin
Journal:  Am J Clin Pathol       Date:  1973-12       Impact factor: 2.493

5.  Proteus infections in a general hospital. II. Some clinical and epidemiological characteristis. With an analysis of 71 cases of proteus bacteremia.

Authors:  J L Adler; J P Burke; D F Martin; M Finland
Journal:  Ann Intern Med       Date:  1971-10       Impact factor: 25.391

6.  A new species of Proteus isolated from larvae of the gypsy moth Porthetria dispar (L.).

Authors:  B J Cosenza; J D Podgwaite
Journal:  Antonie Van Leeuwenhoek       Date:  1966       Impact factor: 2.271

7.  Emergence of resistance of Providencia stuartii to multiple antibiotics: speciation and biochemical characterization of Providencia.

Authors:  G D Overturf; J Wilkins; R Ressler
Journal:  J Infect Dis       Date:  1974-03       Impact factor: 5.226

8.  Biotypes of Proteus rettgeri.

Authors:  J L Penner; N A Hinton; J Hennessy
Journal:  J Clin Microbiol       Date:  1975-02       Impact factor: 5.948

9.  Three episodes of nosocomial urinary tract infections caused by one O-serotype of Providencia stuartii.

Authors:  J L Penner; N A Hinton; L J Hamilton; J N Hennessy
Journal:  J Urol       Date:  1981-05       Impact factor: 7.450

10.  Differences among Providencia species in their in vitro susceptibilities to five antibiotics.

Authors:  J L Penner; M A Preston
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

View more
  9 in total

1.  Activities of oral antibiotics on Providencia strains isolated from institutionalized elderly patients with urinary tract infections.

Authors:  G Cornaglia; S Frugoni; A Mazzariol; E Piacentini; A Berlusconi; R Fontana
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

2.  Susceptibilities of 45 clinical isolates of Proteus penneri.

Authors:  M Fuksa; S Krajden; A Lee
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

3.  Comparative in vitro activity of semisynthetic penicillins against Proteeae.

Authors:  P M Hawkey; S J Pedler; A Turner
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

4.  Use of a novel phosphatase test for simplified identification of species of the tribe Proteeae.

Authors:  R Pompei; G Cornaglia; A Ingianni; G Satta
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

5.  Speciation, serotyping, antimicrobial sensitivity and plasmid content of Proteeae from the environment of calf-rearing units in South West England.

Authors:  P M Hawkey; J L Penner; A H Linton; C A Hawkey; L J Crisp; M Hinton
Journal:  J Hyg (Lond)       Date:  1986-12

6.  Commercial identification systems often fail to identify Providencia stuartii.

Authors:  G Cornaglia; B Dainelli; F Berlutti; M C Thaller
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

7.  Modified MacConkey medium which allows simple and reliable identification of Providencia stuartii.

Authors:  M C Thaller; F Berlutti; F Pantanella; R Pompei; G Satta
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

8.  Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections.

Authors:  R Piccolomini; L Cellini; N Allocati; A Di Girolamo; G Ravagnan
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

Review 9.  Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.